While formularies should provide physicians the ability to treat any patient that walks into the office, there also need to be clinical exceptions that allow patients with mitigating circumstances to get any product clinically necessary.
While formularies should provide physicians the ability to treat any patient that walks into the office, there also need to be clinical exceptions that allow patients with mitigating circumstances to get any product clinically necessary, said Steven Miller, MD, MBA.
“Clearly doctors and patients would like unfettered access to all products, but we know that the economic reality resulting in that would be much, much higher drug costs,” he said.
Keith Hoffman, Phd, would like to see more analysis of post-marketing adverse event data included in formulary decisions.
“The ramifications for patient safety are not all the way figured out prior to the release of the drugs,” he explained.
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen